LUNG vs SYK

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 16, 2026

LUNG

32.7
AI Score
VS
SYK Wins

SYK

36.7
AI Score

Investment Advisor Scores

LUNG

33score
Recommendation
AVOID NEW MONEY

SYK

37score
Recommendation
AVOID NEW MONEY

Detailed Metrics Comparison

Metric LUNG SYK Winner
Forward P/E -3.1 19.0 Tie
PEG Ratio 0.0 1.54 Tie
Revenue Growth 6.2% 7.6% SYK
Earnings Growth 0.0% -11.7% LUNG
Tradestie Score 32.7/100 36.7/100 SYK
Profit Margin -47.9% 13.8% SYK
Beta 1.00 1.00 Tie
AI Recommendation AVOID NEW MONEY AVOID NEW MONEY Tie

Relative Price Performance (Last 90 Days)

LUNG 1M: +54.6% · 3M: +28.3% SYK 1M: +5.6% · 3M: -6.6%

Current Technical Phase

LUNG

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.3% over 20 days), RSI 61

RSI (14): 61.4 · Price: $2.86

SYK

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.9 · Price: $309.64

Fundamentals Snapshot

Metric LUNG SYK
Market Cap — —
Forward P/E -3.1 19.0
Trailing P/E — 33.3
Revenue (TTM) — —
Revenue Growth 6.2% 7.6%
Gross Margin 77.4% 65.7%
Operating Margin -44.4% 24.0%
EPS -1.01 9.39
Dividend Yield — 1.10%

Frequently Asked Questions

Based on our detailed analysis, SYK is currently the stronger investment candidate with a higher AI composite score (36.7/100 vs. 32.7/100), supported by its current technical phase (LUNG: Markup, SYK: Neutral) and fundamental profile.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.